Published in Cancer Weekly, July 14th, 1997
Under the terms of the agreement, Bayer manufactures Mycelex Troche for Alza, and Alza makes payments to Bayer based on net sales of the product.
As a result of the agreement, Alza has exclusive marketing rights to Mycelex Troche in the United States. Since 1996, Alza has promoted Mycelex Troche under a promotion agreement with Bayer to AIDS healthcare providers, AIDS clinics, hospitals specializing in the treatment of AIDS patients, and to oncologists.
"The acquisition of Mycelex Troche...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.